Original Research
Published on 28 Jan 2020
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
in Cancer Immunity and Immunotherapy

- 14,514 views
- 37 citations
Original Research
Published on 28 Jan 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 28 Jan 2020
in Multiple Sclerosis and Neuroimmunology

Editorial
Published on 28 Jan 2020
in B Cell Biology
Original Research
Published on 28 Jan 2020
in Inflammation

Original Research
Published on 28 Jan 2020
in Comparative Immunology

Mini Review
Published on 28 Jan 2020
in Molecular Innate Immunity

Original Research
Published on 28 Jan 2020
in Microbial Immunology

Original Research
Published on 28 Jan 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 28 Jan 2020
in Immunological Tolerance and Regulation

Mini Review
Published on 28 Jan 2020
in Autoimmune and Autoinflammatory Disorders

Original Research
Published on 28 Jan 2020
in Comparative Immunology

Review
Published on 28 Jan 2020
in Cancer Immunity and Immunotherapy

Review
Published on 28 Jan 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 27 Jan 2020
in Primary Immunodeficiencies

Original Research
Published on 27 Jan 2020
in Cytokines and Soluble Mediators in Immunity

Review
Published on 24 Jan 2020
in Inflammation
